NCT02094612

Effectiveness of the Quotient® ADHD Assessment in a System of Care

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 207 (actual)
• Sponsor: Kaiser Permanente · Academic / Other
• Sex: All
• Age: 6 Years – 12 Years
• Healthy volunteers: Not accepted

Summary

The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.

Detailed description

This study is a randomized, controlled trial using a 2-phase data collection. The first phase is the initial assessment for ADHD and includes all patients eligible to be assessed for ADHD as determined by their clinician in the course of usual care. The baseline measurements will be used to compare groups at baseline, and also for longitudinal analyses of medication management. Patients are randomized at this point. Patients in both treatment arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible for the second phase of the study: three follow-up assessments over six months. Patients who do not have an ADHD diagnosis will not continue in the study, and will be treated by their clinician as usual.

Conditions

• Attention Deficit and Disruptive Behavior Disorders
• Attention Deficit Disorder With Hyperactivity

Interventions

Type	Name	Description
DEVICE	Quotient®	Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.
BEHAVIORAL	Usual Clinic ADHD Care	Usual ADHD care as provided by the clinic

Timeline

• Start date: 2014-03-01
• Primary completion: 2015-08-01
• Completion: 2015-08-01
• First posted: 2014-03-24
• Last updated: 2017-07-17
• Results posted: 2017-07-17

Locations

3 sites across 1 country: United States